The Global Health Connector has been a mainstay of HLTH since its US debut in 2017. Watching HLTH Europe successfully translate that signature energy into the European market has been a highlight for the digital health community.
This year, Global Health Connector returns to host the Partner Programme, “Connecting the Dots, Transforming Lives,” on Monday, 15 June (13:00–17:00 CET) at HLTH Europe 2026. Ahead of the event, we sat down with Professor Anne Moen, a featured speaker on the high-impact panel “Beyond the Pilot: Turning Digital Health Innovation into Real-World Impact.”
Anne is a Full Professor at the University of Oslo, Faculty of Medicine, an Adjunct Professor at the Norwegian Center for eHealth Research, Tromsø, Norway, and Director of UiO:eColab. Her work is at the cutting edge of patient-focused interventions, particularly through the Gravitate-Health initiative.
Anne, can you tell us a little about your journey and what drives your work in digital health?
Anne Moen: My work is centered on technology-mediated interventions that sustain health and wellbeing. At the University of Oslo’s eColab, we focus on the ability to “collect, curate, and control” all relevant personal health information.
I am excited about Gravitate-Health and our contribution to developing and testing innovative, easy-to-use, elegant digital services that actively engage and empower citizens and their support networks, providing access to—and understanding of—health information from trusted sources.
At Global Health Connector, we champion ‘CollaborAction’—collaboration plus action. In your view, why is this philosophy so vital for driving impact?
Anne Moen: I think having a diverse network and bringing people and institutions together is important, and that engaging in concrete activities and real-world problems is key to driving value creation and impact.
What can attendees expect from your session, and what makes the Global Health Connector Partner Programme unmissable?
Anne Moen: I will be discussing a specific formula for impact: (epP–eD)+ePI(epP–eD)+ePI, which starts with ePrescription and eDispensation and augments the service with medicinal product information (ePI) in the language of choice (complementing the language of the jurisdiction where a product is dispensed).
Leveraging standards (e.g., ePI and IDMP) and experimenting with AI are examples that help mitigate reported language challenges. This approach adds health information from trusted sources to drive real-world impact, patient engagement, and safer use of medicines.
Don’t miss Professor Anne Moen and the Global Health Connector team at HLTH Europe 2026.